Caribou Biosciences (CRBU) Operating Leases (2022 - 2025)
Historic Operating Leases for Caribou Biosciences (CRBU) over the last 4 years, with Q3 2025 value amounting to $22.8 million.
- Caribou Biosciences' Operating Leases fell 1450.4% to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.8 million, marking a year-over-year decrease of 1450.4%. This contributed to the annual value of $25.1 million for FY2024, which is 326.93% down from last year.
- Per Caribou Biosciences' latest filing, its Operating Leases stood at $22.8 million for Q3 2025, which was down 1450.4% from $23.6 million recorded in Q2 2025.
- Over the past 5 years, Caribou Biosciences' Operating Leases peaked at $27.9 million during Q3 2022, and registered a low of $22.8 million during Q3 2025.
- Moreover, its 4-year median value for Operating Leases was $26.8 million (2024), whereas its average is $26.2 million.
- In the last 5 years, Caribou Biosciences' Operating Leases surged by 67.92% in 2023 and then crashed by 1450.4% in 2025.
- Caribou Biosciences' Operating Leases (Quarter) stood at $26.8 million in 2022, then dropped by 3.26% to $25.9 million in 2023, then fell by 3.27% to $25.1 million in 2024, then dropped by 9.11% to $22.8 million in 2025.
- Its Operating Leases was $22.8 million in Q3 2025, compared to $23.6 million in Q2 2025 and $24.3 million in Q1 2025.